nodes	percent_of_prediction	percent_of_DWPC	metapath
Glucosamine—MMP9—urinary bladder cancer	0.293	0.604	CbGaD
Glucosamine—TNF—urinary bladder cancer	0.193	0.397	CbGaD
Glucosamine—Cytarabine—Gemcitabine—urinary bladder cancer	0.185	0.513	CrCrCtD
Glucosamine—Azacitidine—Gemcitabine—urinary bladder cancer	0.175	0.487	CrCrCtD
Glucosamine—NFKB2—prostate gland—urinary bladder cancer	0.00502	0.117	CbGeAlD
Glucosamine—NFKB2—urethra—urinary bladder cancer	0.00336	0.0783	CbGeAlD
Glucosamine—Cytarabine—POLB—urinary bladder cancer	0.00276	1	CrCbGaD
Glucosamine—NFKB2—female reproductive system—urinary bladder cancer	0.00274	0.0638	CbGeAlD
Glucosamine—CYP2C19—urine—urinary bladder cancer	0.00273	0.0636	CbGeAlD
Glucosamine—TNF—vagina—urinary bladder cancer	0.00251	0.0586	CbGeAlD
Glucosamine—IFNG—epithelium—urinary bladder cancer	0.0025	0.0582	CbGeAlD
Glucosamine—IFNG—renal system—urinary bladder cancer	0.00232	0.054	CbGeAlD
Glucosamine—MMP9—prostate gland—urinary bladder cancer	0.00218	0.0509	CbGeAlD
Glucosamine—CYP2E1—urine—urinary bladder cancer	0.002	0.0467	CbGeAlD
Glucosamine—IFNG—female reproductive system—urinary bladder cancer	0.00186	0.0433	CbGeAlD
Glucosamine—IFNG—vagina—urinary bladder cancer	0.00168	0.0391	CbGeAlD
Glucosamine—TNF—lymph node—urinary bladder cancer	0.00163	0.0379	CbGeAlD
Glucosamine—MMP9—epithelium—urinary bladder cancer	0.00161	0.0374	CbGeAlD
Glucosamine—NFKB2—lymph node—urinary bladder cancer	0.0016	0.0373	CbGeAlD
Glucosamine—MMP9—smooth muscle tissue—urinary bladder cancer	0.00155	0.036	CbGeAlD
Glucosamine—MMP9—renal system—urinary bladder cancer	0.00149	0.0347	CbGeAlD
Glucosamine—MMP9—female reproductive system—urinary bladder cancer	0.00119	0.0278	CbGeAlD
Glucosamine—IFNG—lymph node—urinary bladder cancer	0.00109	0.0253	CbGeAlD
Glucosamine—CYP2E1—prostate gland—urinary bladder cancer	0.00072	0.0168	CbGeAlD
Glucosamine—MMP9—lymph node—urinary bladder cancer	0.000698	0.0162	CbGeAlD
Glucosamine—CYP2E1—seminal vesicle—urinary bladder cancer	0.000609	0.0142	CbGeAlD
Glucosamine—CYP2E1—renal system—urinary bladder cancer	0.000491	0.0114	CbGeAlD
Glucosamine—CYP2C19—vagina—urinary bladder cancer	0.000484	0.0113	CbGeAlD
Glucosamine—CYP2E1—urethra—urinary bladder cancer	0.000482	0.0112	CbGeAlD
Glucosamine—CYP2E1—female reproductive system—urinary bladder cancer	0.000393	0.00915	CbGeAlD
Glucosamine—TNF—Allograft Rejection—IL2—urinary bladder cancer	5.7e-05	0.000524	CbGpPWpGaD
Glucosamine—TNF—Selenium Micronutrient Network—PTGS2—urinary bladder cancer	5.64e-05	0.000518	CbGpPWpGaD
Glucosamine—TNF—Signaling events mediated by HDAC Class I—EP300—urinary bladder cancer	5.63e-05	0.000518	CbGpPWpGaD
Glucosamine—TNF—Integrated Pancreatic Cancer Pathway—CCNE1—urinary bladder cancer	5.54e-05	0.00051	CbGpPWpGaD
Glucosamine—MMP9—Signaling by SCF-KIT—CDKN1A—urinary bladder cancer	5.52e-05	0.000507	CbGpPWpGaD
Glucosamine—CYP2E1—Biological oxidations—HPGDS—urinary bladder cancer	5.52e-05	0.000507	CbGpPWpGaD
Glucosamine—MMP9—Signaling by SCF-KIT—PTEN—urinary bladder cancer	5.51e-05	0.000506	CbGpPWpGaD
Glucosamine—NFKB2—Cytokine Signaling in Immune system—IL2—urinary bladder cancer	5.51e-05	0.000506	CbGpPWpGaD
Glucosamine—TNF—Integrated Pancreatic Cancer Pathway—TYMS—urinary bladder cancer	5.45e-05	0.0005	CbGpPWpGaD
Glucosamine—TNF—Spinal Cord Injury—RB1—urinary bladder cancer	5.43e-05	0.000499	CbGpPWpGaD
Glucosamine—TNF—Aryl Hydrocarbon Receptor—HRAS—urinary bladder cancer	5.4e-05	0.000496	CbGpPWpGaD
Glucosamine—CYP2E1—Biological oxidations—GSTT1—urinary bladder cancer	5.35e-05	0.000492	CbGpPWpGaD
Glucosamine—TNF—MAPK Signaling Pathway—FAS—urinary bladder cancer	5.35e-05	0.000491	CbGpPWpGaD
Glucosamine—CYP2C19—Biological oxidations—NAT2—urinary bladder cancer	5.32e-05	0.000489	CbGpPWpGaD
Glucosamine—NFKB2—Immune System—RBX1—urinary bladder cancer	5.28e-05	0.000486	CbGpPWpGaD
Glucosamine—MMP9—Spinal Cord Injury—MYC—urinary bladder cancer	5.28e-05	0.000485	CbGpPWpGaD
Glucosamine—CYP2C19—Metapathway biotransformation—NAT2—urinary bladder cancer	5.25e-05	0.000482	CbGpPWpGaD
Glucosamine—TNF—Adipogenesis—PPARG—urinary bladder cancer	5.25e-05	0.000482	CbGpPWpGaD
Glucosamine—TNF—Transcriptional regulation of white adipocyte differentiation—EP300—urinary bladder cancer	5.22e-05	0.00048	CbGpPWpGaD
Glucosamine—IFNG—Immune System—BIRC3—urinary bladder cancer	5.21e-05	0.000479	CbGpPWpGaD
Glucosamine—MMP9—Spinal Cord Injury—EGFR—urinary bladder cancer	5.16e-05	0.000475	CbGpPWpGaD
Glucosamine—MMP9—Signaling by SCF-KIT—SRC—urinary bladder cancer	5.11e-05	0.00047	CbGpPWpGaD
Glucosamine—TNF—Adipogenesis—RB1—urinary bladder cancer	5.02e-05	0.000462	CbGpPWpGaD
Glucosamine—TNF—Adipogenesis—IGF1—urinary bladder cancer	4.98e-05	0.000457	CbGpPWpGaD
Glucosamine—MMP9—EPH-Ephrin signaling—HRAS—urinary bladder cancer	4.97e-05	0.000457	CbGpPWpGaD
Glucosamine—TNF—Spinal Cord Injury—RHOA—urinary bladder cancer	4.93e-05	0.000453	CbGpPWpGaD
Glucosamine—MMP9—Spinal Cord Injury—TNF—urinary bladder cancer	4.92e-05	0.000452	CbGpPWpGaD
Glucosamine—TNF—Toll-like Receptor Signaling Pathway—CXCL8—urinary bladder cancer	4.86e-05	0.000447	CbGpPWpGaD
Glucosamine—TNF—Integrated Pancreatic Cancer Pathway—FAS—urinary bladder cancer	4.83e-05	0.000443	CbGpPWpGaD
Glucosamine—NFKB2—Innate Immune System—FGFR3—urinary bladder cancer	4.78e-05	0.000439	CbGpPWpGaD
Glucosamine—TNF—Downstream signaling in naïve CD8+ T cells—KRAS—urinary bladder cancer	4.76e-05	0.000437	CbGpPWpGaD
Glucosamine—TNF—TGF-beta Receptor Signaling—HRAS—urinary bladder cancer	4.75e-05	0.000436	CbGpPWpGaD
Glucosamine—MMP9—Extracellular matrix organization—CDH1—urinary bladder cancer	4.64e-05	0.000426	CbGpPWpGaD
Glucosamine—MMP9—Signaling by SCF-KIT—EGFR—urinary bladder cancer	4.48e-05	0.000412	CbGpPWpGaD
Glucosamine—IFNG—Cytokine Signaling in Immune system—IL2—urinary bladder cancer	4.46e-05	0.00041	CbGpPWpGaD
Glucosamine—TNF—Spinal Cord Injury—PTGS2—urinary bladder cancer	4.46e-05	0.00041	CbGpPWpGaD
Glucosamine—TNF—SIDS Susceptibility Pathways—CREBBP—urinary bladder cancer	4.36e-05	0.0004	CbGpPWpGaD
Glucosamine—TNF—Apoptosis—CDH1—urinary bladder cancer	4.35e-05	0.000399	CbGpPWpGaD
Glucosamine—MMP9—Spinal Cord Injury—TP53—urinary bladder cancer	4.34e-05	0.000398	CbGpPWpGaD
Glucosamine—TNF—Spinal Cord Injury—CXCL8—urinary bladder cancer	4.33e-05	0.000398	CbGpPWpGaD
Glucosamine—IFNG—Immune System—RBX1—urinary bladder cancer	4.28e-05	0.000393	CbGpPWpGaD
Glucosamine—TNF—Integrated Pancreatic Cancer Pathway—ATM—urinary bladder cancer	4.26e-05	0.000392	CbGpPWpGaD
Glucosamine—CYP2C19—Biological oxidations—HPGDS—urinary bladder cancer	4.26e-05	0.000391	CbGpPWpGaD
Glucosamine—TNF—Integrated Pancreatic Cancer Pathway—CDK4—urinary bladder cancer	4.25e-05	0.00039	CbGpPWpGaD
Glucosamine—TNF—Apoptosis—MYC—urinary bladder cancer	4.24e-05	0.00039	CbGpPWpGaD
Glucosamine—MMP9—Signaling by SCF-KIT—KRAS—urinary bladder cancer	4.23e-05	0.000389	CbGpPWpGaD
Glucosamine—TNF—Integrated Pancreatic Cancer Pathway—ESR1—urinary bladder cancer	4.23e-05	0.000389	CbGpPWpGaD
Glucosamine—TNF—Folate Metabolism—TP53—urinary bladder cancer	4.23e-05	0.000388	CbGpPWpGaD
Glucosamine—TNF—Spinal Cord Injury—IL2—urinary bladder cancer	4.13e-05	0.00038	CbGpPWpGaD
Glucosamine—CYP2C19—Biological oxidations—GSTT1—urinary bladder cancer	4.13e-05	0.000379	CbGpPWpGaD
Glucosamine—MMP9—Developmental Biology—NCOR1—urinary bladder cancer	4.11e-05	0.000378	CbGpPWpGaD
Glucosamine—NFKB2—Innate Immune System—CREBBP—urinary bladder cancer	4.07e-05	0.000374	CbGpPWpGaD
Glucosamine—NFKB2—Immune System—IFNA2—urinary bladder cancer	4.05e-05	0.000372	CbGpPWpGaD
Glucosamine—TNF—Downstream signaling in naïve CD8+ T cells—HRAS—urinary bladder cancer	4.04e-05	0.000371	CbGpPWpGaD
Glucosamine—TNF—Spinal Cord Injury—CCND1—urinary bladder cancer	4.03e-05	0.00037	CbGpPWpGaD
Glucosamine—CYP2C19—Arachidonic acid metabolism—PTGS2—urinary bladder cancer	3.98e-05	0.000366	CbGpPWpGaD
Glucosamine—NFKB2—Cytokine Signaling in Immune system—KRAS—urinary bladder cancer	3.98e-05	0.000366	CbGpPWpGaD
Glucosamine—TNF—Spinal Cord Injury—MMP9—urinary bladder cancer	3.91e-05	0.00036	CbGpPWpGaD
Glucosamine—NFKB2—Immune System—S100B—urinary bladder cancer	3.83e-05	0.000352	CbGpPWpGaD
Glucosamine—TNF—Regulation of toll-like receptor signaling pathway—CXCL8—urinary bladder cancer	3.8e-05	0.000349	CbGpPWpGaD
Glucosamine—CYP2E1—Biological oxidations—GSTP1—urinary bladder cancer	3.71e-05	0.000341	CbGpPWpGaD
Glucosamine—TNF—Integrated Pancreatic Cancer Pathway—CREBBP—urinary bladder cancer	3.71e-05	0.000341	CbGpPWpGaD
Glucosamine—TNF—Alzheimers Disease—TP53—urinary bladder cancer	3.66e-05	0.000336	CbGpPWpGaD
Glucosamine—TNF—Integrated Pancreatic Cancer Pathway—IGF1—urinary bladder cancer	3.66e-05	0.000336	CbGpPWpGaD
Glucosamine—CYP2E1—Metapathway biotransformation—GSTP1—urinary bladder cancer	3.66e-05	0.000336	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—HDAC4—urinary bladder cancer	3.65e-05	0.000336	CbGpPWpGaD
Glucosamine—TNF—TNF alpha Signaling Pathway—KRAS—urinary bladder cancer	3.65e-05	0.000335	CbGpPWpGaD
Glucosamine—TNF—Adipogenesis—CDKN1A—urinary bladder cancer	3.61e-05	0.000332	CbGpPWpGaD
Glucosamine—MMP9—Signaling by SCF-KIT—HRAS—urinary bladder cancer	3.6e-05	0.00033	CbGpPWpGaD
Glucosamine—MMP9—Axon guidance—RHOA—urinary bladder cancer	3.59e-05	0.00033	CbGpPWpGaD
Glucosamine—TNF—Apoptosis—TP53—urinary bladder cancer	3.48e-05	0.00032	CbGpPWpGaD
Glucosamine—TNF—SIDS Susceptibility Pathways—CXCL8—urinary bladder cancer	3.46e-05	0.000318	CbGpPWpGaD
Glucosamine—NFKB2—Innate Immune System—ERBB2—urinary bladder cancer	3.41e-05	0.000313	CbGpPWpGaD
Glucosamine—CYP2E1—Biological oxidations—GSTM1—urinary bladder cancer	3.41e-05	0.000313	CbGpPWpGaD
Glucosamine—NFKB2—Cytokine Signaling in Immune system—HRAS—urinary bladder cancer	3.38e-05	0.000311	CbGpPWpGaD
Glucosamine—CYP2E1—Metapathway biotransformation—GSTM1—urinary bladder cancer	3.36e-05	0.000309	CbGpPWpGaD
Glucosamine—MMP9—Axon guidance—ERBB2—urinary bladder cancer	3.32e-05	0.000305	CbGpPWpGaD
Glucosamine—IFNG—Immune System—IFNA2—urinary bladder cancer	3.28e-05	0.000302	CbGpPWpGaD
Glucosamine—MMP9—Developmental Biology—CDK4—urinary bladder cancer	3.24e-05	0.000298	CbGpPWpGaD
Glucosamine—TNF—Spinal Cord Injury—MYC—urinary bladder cancer	3.23e-05	0.000297	CbGpPWpGaD
Glucosamine—IFNG—Cytokine Signaling in Immune system—KRAS—urinary bladder cancer	3.22e-05	0.000296	CbGpPWpGaD
Glucosamine—TNF—Spinal Cord Injury—EGFR—urinary bladder cancer	3.16e-05	0.000291	CbGpPWpGaD
Glucosamine—TNF—Integrated Pancreatic Cancer Pathway—ERBB2—urinary bladder cancer	3.1e-05	0.000285	CbGpPWpGaD
Glucosamine—IFNG—Immune System—S100B—urinary bladder cancer	3.1e-05	0.000285	CbGpPWpGaD
Glucosamine—TNF—TNF alpha Signaling Pathway—HRAS—urinary bladder cancer	3.1e-05	0.000285	CbGpPWpGaD
Glucosamine—CYP2C19—Metabolism of lipids and lipoproteins—CYP4B1—urinary bladder cancer	3.07e-05	0.000282	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—GLI1—urinary bladder cancer	3.06e-05	0.000281	CbGpPWpGaD
Glucosamine—TNF—Integrated Pancreatic Cancer Pathway—PTGS2—urinary bladder cancer	3.03e-05	0.000279	CbGpPWpGaD
Glucosamine—TNF—SIDS Susceptibility Pathways—EP300—urinary bladder cancer	2.97e-05	0.000273	CbGpPWpGaD
Glucosamine—MMP9—Developmental Biology—PPARG—urinary bladder cancer	2.95e-05	0.000271	CbGpPWpGaD
Glucosamine—NFKB2—Innate Immune System—CDKN1A—urinary bladder cancer	2.91e-05	0.000268	CbGpPWpGaD
Glucosamine—NFKB2—Innate Immune System—PTEN—urinary bladder cancer	2.91e-05	0.000267	CbGpPWpGaD
Glucosamine—CYP2C19—Biological oxidations—GSTP1—urinary bladder cancer	2.86e-05	0.000263	CbGpPWpGaD
Glucosamine—MMP9—Developmental Biology—CREBBP—urinary bladder cancer	2.83e-05	0.00026	CbGpPWpGaD
Glucosamine—CYP2C19—Metapathway biotransformation—GSTP1—urinary bladder cancer	2.82e-05	0.000259	CbGpPWpGaD
Glucosamine—NFKB2—Immune System—FGFR3—urinary bladder cancer	2.79e-05	0.000256	CbGpPWpGaD
Glucosamine—NFKB2—Innate Immune System—EP300—urinary bladder cancer	2.77e-05	0.000255	CbGpPWpGaD
Glucosamine—TNF—Integrated Pancreatic Cancer Pathway—CCND1—urinary bladder cancer	2.74e-05	0.000252	CbGpPWpGaD
Glucosamine—IFNG—Cytokine Signaling in Immune system—HRAS—urinary bladder cancer	2.74e-05	0.000252	CbGpPWpGaD
Glucosamine—NFKB2—Innate Immune System—SRC—urinary bladder cancer	2.7e-05	0.000248	CbGpPWpGaD
Glucosamine—TNF—Spinal Cord Injury—TP53—urinary bladder cancer	2.66e-05	0.000244	CbGpPWpGaD
Glucosamine—TNF—Integrated Pancreatic Cancer Pathway—CDKN1A—urinary bladder cancer	2.65e-05	0.000244	CbGpPWpGaD
Glucosamine—TNF—Integrated Pancreatic Cancer Pathway—PTEN—urinary bladder cancer	2.65e-05	0.000243	CbGpPWpGaD
Glucosamine—CYP2C19—Biological oxidations—GSTM1—urinary bladder cancer	2.63e-05	0.000242	CbGpPWpGaD
Glucosamine—MMP9—Axon guidance—SRC—urinary bladder cancer	2.63e-05	0.000241	CbGpPWpGaD
Glucosamine—CYP2C19—Metapathway biotransformation—GSTM1—urinary bladder cancer	2.59e-05	0.000238	CbGpPWpGaD
Glucosamine—MMP9—Developmental Biology—RHOA—urinary bladder cancer	2.56e-05	0.000235	CbGpPWpGaD
Glucosamine—TNF—Integrated Pancreatic Cancer Pathway—EP300—urinary bladder cancer	2.52e-05	0.000232	CbGpPWpGaD
Glucosamine—TNF—Developmental Biology—NCOR1—urinary bladder cancer	2.52e-05	0.000231	CbGpPWpGaD
Glucosamine—TNF—Integrated Pancreatic Cancer Pathway—SRC—urinary bladder cancer	2.45e-05	0.000226	CbGpPWpGaD
Glucosamine—TNF—MAPK Signaling Pathway—MYC—urinary bladder cancer	2.44e-05	0.000224	CbGpPWpGaD
Glucosamine—TNF—MAPK Signaling Pathway—EGFR—urinary bladder cancer	2.38e-05	0.000219	CbGpPWpGaD
Glucosamine—NFKB2—Immune System—CREBBP—urinary bladder cancer	2.37e-05	0.000218	CbGpPWpGaD
Glucosamine—MMP9—Developmental Biology—ERBB2—urinary bladder cancer	2.37e-05	0.000218	CbGpPWpGaD
Glucosamine—NFKB2—Innate Immune System—EGFR—urinary bladder cancer	2.36e-05	0.000217	CbGpPWpGaD
Glucosamine—NFKB2—Immune System—CDH1—urinary bladder cancer	2.35e-05	0.000216	CbGpPWpGaD
Glucosamine—MMP9—Axon guidance—EGFR—urinary bladder cancer	2.3e-05	0.000212	CbGpPWpGaD
Glucosamine—CYP2E1—Metabolism—GSTZ1—urinary bladder cancer	2.27e-05	0.000209	CbGpPWpGaD
Glucosamine—IFNG—Immune System—FGFR3—urinary bladder cancer	2.26e-05	0.000207	CbGpPWpGaD
Glucosamine—TNF—MAPK Signaling Pathway—KRAS—urinary bladder cancer	2.25e-05	0.000207	CbGpPWpGaD
Glucosamine—NFKB2—Innate Immune System—KRAS—urinary bladder cancer	2.23e-05	0.000205	CbGpPWpGaD
Glucosamine—TNF—Integrated Pancreatic Cancer Pathway—MYC—urinary bladder cancer	2.2e-05	0.000202	CbGpPWpGaD
Glucosamine—MMP9—Axon guidance—KRAS—urinary bladder cancer	2.17e-05	0.0002	CbGpPWpGaD
Glucosamine—CYP2E1—Metabolism—GSTO2—urinary bladder cancer	2.15e-05	0.000198	CbGpPWpGaD
Glucosamine—CYP2E1—Metabolism—NAT1—urinary bladder cancer	2.15e-05	0.000198	CbGpPWpGaD
Glucosamine—TNF—Integrated Pancreatic Cancer Pathway—EGFR—urinary bladder cancer	2.15e-05	0.000198	CbGpPWpGaD
Glucosamine—TNF—Apoptosis—TP53—urinary bladder cancer	2.13e-05	0.000196	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—RBX1—urinary bladder cancer	2.1e-05	0.000193	CbGpPWpGaD
Glucosamine—TNF—Integrated Pancreatic Cancer Pathway—KRAS—urinary bladder cancer	2.03e-05	0.000187	CbGpPWpGaD
Glucosamine—TNF—MAPK Signaling Pathway—TP53—urinary bladder cancer	2e-05	0.000184	CbGpPWpGaD
Glucosamine—NFKB2—Immune System—ERBB2—urinary bladder cancer	1.99e-05	0.000182	CbGpPWpGaD
Glucosamine—TNF—Developmental Biology—CDK4—urinary bladder cancer	1.99e-05	0.000182	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—TSC1—urinary bladder cancer	1.97e-05	0.000181	CbGpPWpGaD
Glucosamine—CYP2E1—Metabolism—UGT2B7—urinary bladder cancer	1.97e-05	0.000181	CbGpPWpGaD
Glucosamine—MMP9—Developmental Biology—EP300—urinary bladder cancer	1.93e-05	0.000177	CbGpPWpGaD
Glucosamine—IFNG—Immune System—CREBBP—urinary bladder cancer	1.92e-05	0.000177	CbGpPWpGaD
Glucosamine—IFNG—Immune System—CDH1—urinary bladder cancer	1.91e-05	0.000175	CbGpPWpGaD
Glucosamine—NFKB2—Innate Immune System—HRAS—urinary bladder cancer	1.9e-05	0.000174	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—JAG1—urinary bladder cancer	1.88e-05	0.000173	CbGpPWpGaD
Glucosamine—MMP9—Developmental Biology—SRC—urinary bladder cancer	1.87e-05	0.000172	CbGpPWpGaD
Glucosamine—MMP9—Axon guidance—HRAS—urinary bladder cancer	1.85e-05	0.00017	CbGpPWpGaD
Glucosamine—TNF—Integrated Pancreatic Cancer Pathway—TP53—urinary bladder cancer	1.81e-05	0.000166	CbGpPWpGaD
Glucosamine—TNF—Developmental Biology—PPARG—urinary bladder cancer	1.8e-05	0.000166	CbGpPWpGaD
Glucosamine—NFKB2—Immune System—IL2—urinary bladder cancer	1.8e-05	0.000165	CbGpPWpGaD
Glucosamine—CYP2E1—Metabolism—CYP4B1—urinary bladder cancer	1.77e-05	0.000163	CbGpPWpGaD
Glucosamine—CYP2C19—Metabolism—GSTZ1—urinary bladder cancer	1.75e-05	0.000161	CbGpPWpGaD
Glucosamine—TNF—Developmental Biology—CREBBP—urinary bladder cancer	1.73e-05	0.000159	CbGpPWpGaD
Glucosamine—NFKB2—Immune System—CDKN1A—urinary bladder cancer	1.7e-05	0.000156	CbGpPWpGaD
Glucosamine—NFKB2—Immune System—PTEN—urinary bladder cancer	1.69e-05	0.000156	CbGpPWpGaD
Glucosamine—CYP2E1—Metabolism—SLC19A1—urinary bladder cancer	1.67e-05	0.000154	CbGpPWpGaD
Glucosamine—CYP2C19—Metabolism—GSTO2—urinary bladder cancer	1.66e-05	0.000153	CbGpPWpGaD
Glucosamine—CYP2C19—Metabolism—NAT1—urinary bladder cancer	1.66e-05	0.000153	CbGpPWpGaD
Glucosamine—MMP9—Developmental Biology—EGFR—urinary bladder cancer	1.64e-05	0.000151	CbGpPWpGaD
Glucosamine—CYP2C19—Metabolism of lipids and lipoproteins—HPGDS—urinary bladder cancer	1.63e-05	0.00015	CbGpPWpGaD
Glucosamine—CYP2E1—Metabolism—PRSS3—urinary bladder cancer	1.63e-05	0.00015	CbGpPWpGaD
Glucosamine—NFKB2—Immune System—EP300—urinary bladder cancer	1.61e-05	0.000148	CbGpPWpGaD
Glucosamine—IFNG—Immune System—ERBB2—urinary bladder cancer	1.61e-05	0.000148	CbGpPWpGaD
Glucosamine—NFKB2—Immune System—SRC—urinary bladder cancer	1.57e-05	0.000144	CbGpPWpGaD
Glucosamine—TNF—Developmental Biology—RHOA—urinary bladder cancer	1.57e-05	0.000144	CbGpPWpGaD
Glucosamine—MMP9—Developmental Biology—TNF—urinary bladder cancer	1.56e-05	0.000144	CbGpPWpGaD
Glucosamine—MMP9—Developmental Biology—KRAS—urinary bladder cancer	1.55e-05	0.000143	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—S100B—urinary bladder cancer	1.52e-05	0.00014	CbGpPWpGaD
Glucosamine—CYP2C19—Metabolism—UGT2B7—urinary bladder cancer	1.52e-05	0.00014	CbGpPWpGaD
Glucosamine—IFNG—Immune System—IL2—urinary bladder cancer	1.46e-05	0.000134	CbGpPWpGaD
Glucosamine—TNF—Developmental Biology—ERBB2—urinary bladder cancer	1.45e-05	0.000133	CbGpPWpGaD
Glucosamine—NFKB2—Immune System—EGFR—urinary bladder cancer	1.38e-05	0.000126	CbGpPWpGaD
Glucosamine—IFNG—Immune System—CDKN1A—urinary bladder cancer	1.37e-05	0.000126	CbGpPWpGaD
Glucosamine—IFNG—Immune System—PTEN—urinary bladder cancer	1.37e-05	0.000126	CbGpPWpGaD
Glucosamine—CYP2C19—Metabolism—CYP4B1—urinary bladder cancer	1.37e-05	0.000126	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—NCOR1—urinary bladder cancer	1.37e-05	0.000126	CbGpPWpGaD
Glucosamine—MMP9—Developmental Biology—HRAS—urinary bladder cancer	1.32e-05	0.000121	CbGpPWpGaD
Glucosamine—IFNG—Immune System—EP300—urinary bladder cancer	1.31e-05	0.00012	CbGpPWpGaD
Glucosamine—CYP2E1—Metabolism—TYMP—urinary bladder cancer	1.3e-05	0.00012	CbGpPWpGaD
Glucosamine—NFKB2—Immune System—KRAS—urinary bladder cancer	1.3e-05	0.000119	CbGpPWpGaD
Glucosamine—CYP2C19—Metabolism—SLC19A1—urinary bladder cancer	1.29e-05	0.000119	CbGpPWpGaD
Glucosamine—IFNG—Immune System—SRC—urinary bladder cancer	1.27e-05	0.000117	CbGpPWpGaD
Glucosamine—CYP2C19—Metabolism—PRSS3—urinary bladder cancer	1.26e-05	0.000116	CbGpPWpGaD
Glucosamine—TNF—Developmental Biology—MMP9—urinary bladder cancer	1.24e-05	0.000114	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—TERT—urinary bladder cancer	1.2e-05	0.000111	CbGpPWpGaD
Glucosamine—TNF—Developmental Biology—EP300—urinary bladder cancer	1.18e-05	0.000108	CbGpPWpGaD
Glucosamine—CYP2E1—Metabolism—NAT2—urinary bladder cancer	1.18e-05	0.000108	CbGpPWpGaD
Glucosamine—TNF—Developmental Biology—SRC—urinary bladder cancer	1.15e-05	0.000105	CbGpPWpGaD
Glucosamine—IFNG—Immune System—EGFR—urinary bladder cancer	1.12e-05	0.000102	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—FGFR3—urinary bladder cancer	1.11e-05	0.000102	CbGpPWpGaD
Glucosamine—NFKB2—Immune System—HRAS—urinary bladder cancer	1.11e-05	0.000102	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—ESR1—urinary bladder cancer	1.07e-05	9.87e-05	CbGpPWpGaD
Glucosamine—IFNG—Immune System—KRAS—urinary bladder cancer	1.05e-05	9.68e-05	CbGpPWpGaD
Glucosamine—CYP2E1—Metabolism—RRM2—urinary bladder cancer	1.02e-05	9.36e-05	CbGpPWpGaD
Glucosamine—CYP2C19—Metabolism of lipids and lipoproteins—NCOR1—urinary bladder cancer	1.01e-05	9.28e-05	CbGpPWpGaD
Glucosamine—CYP2C19—Metabolism—TYMP—urinary bladder cancer	1.01e-05	9.25e-05	CbGpPWpGaD
Glucosamine—TNF—Developmental Biology—EGFR—urinary bladder cancer	1.01e-05	9.24e-05	CbGpPWpGaD
Glucosamine—CYP2C19—Metabolism of lipids and lipoproteins—GPX1—urinary bladder cancer	9.67e-06	8.88e-05	CbGpPWpGaD
Glucosamine—TNF—Developmental Biology—KRAS—urinary bladder cancer	9.5e-06	8.73e-05	CbGpPWpGaD
Glucosamine—CYP2E1—Metabolism—HPGDS—urinary bladder cancer	9.43e-06	8.67e-05	CbGpPWpGaD
Glucosamine—CYP2E1—Metabolism—ENO2—urinary bladder cancer	9.43e-06	8.67e-05	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—CREBBP—urinary bladder cancer	9.41e-06	8.65e-05	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—IGF1—urinary bladder cancer	9.29e-06	8.54e-05	CbGpPWpGaD
Glucosamine—CYP2E1—Metabolism—GSTT1—urinary bladder cancer	9.15e-06	8.41e-05	CbGpPWpGaD
Glucosamine—CYP2C19—Metabolism—NAT2—urinary bladder cancer	9.1e-06	8.37e-05	CbGpPWpGaD
Glucosamine—IFNG—Immune System—HRAS—urinary bladder cancer	8.95e-06	8.23e-05	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—RHOA—urinary bladder cancer	8.51e-06	7.82e-05	CbGpPWpGaD
Glucosamine—TNF—Developmental Biology—HRAS—urinary bladder cancer	8.08e-06	7.42e-05	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—ERBB2—urinary bladder cancer	7.88e-06	7.24e-05	CbGpPWpGaD
Glucosamine—CYP2C19—Metabolism—RRM2—urinary bladder cancer	7.86e-06	7.22e-05	CbGpPWpGaD
Glucosamine—CYP2E1—Metabolism—NQO1—urinary bladder cancer	7.6e-06	6.99e-05	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—CXCL8—urinary bladder cancer	7.47e-06	6.87e-05	CbGpPWpGaD
Glucosamine—CYP2C19—Metabolism—HPGDS—urinary bladder cancer	7.28e-06	6.69e-05	CbGpPWpGaD
Glucosamine—CYP2C19—Metabolism—ENO2—urinary bladder cancer	7.28e-06	6.69e-05	CbGpPWpGaD
Glucosamine—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—urinary bladder cancer	7.24e-06	6.65e-05	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—IL2—urinary bladder cancer	7.14e-06	6.56e-05	CbGpPWpGaD
Glucosamine—CYP2C19—Metabolism—GSTT1—urinary bladder cancer	7.06e-06	6.49e-05	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—CCND1—urinary bladder cancer	6.96e-06	6.4e-05	CbGpPWpGaD
Glucosamine—CYP2C19—Metabolism of lipids and lipoproteins—CREBBP—urinary bladder cancer	6.95e-06	6.39e-05	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—CDKN1A—urinary bladder cancer	6.74e-06	6.19e-05	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—PTEN—urinary bladder cancer	6.72e-06	6.18e-05	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—EP300—urinary bladder cancer	6.41e-06	5.89e-05	CbGpPWpGaD
Glucosamine—CYP2E1—Metabolism—GSTP1—urinary bladder cancer	6.34e-06	5.83e-05	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—SRC—urinary bladder cancer	6.23e-06	5.73e-05	CbGpPWpGaD
Glucosamine—CYP2E1—Metabolism—TYMS—urinary bladder cancer	5.9e-06	5.42e-05	CbGpPWpGaD
Glucosamine—CYP2C19—Metabolism—NQO1—urinary bladder cancer	5.87e-06	5.39e-05	CbGpPWpGaD
Glucosamine—CYP2E1—Metabolism—NCOR1—urinary bladder cancer	5.83e-06	5.36e-05	CbGpPWpGaD
Glucosamine—CYP2E1—Metabolism—GSTM1—urinary bladder cancer	5.83e-06	5.36e-05	CbGpPWpGaD
Glucosamine—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—urinary bladder cancer	5.69e-06	5.23e-05	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—MYC—urinary bladder cancer	5.59e-06	5.13e-05	CbGpPWpGaD
Glucosamine—CYP2E1—Metabolism—GPX1—urinary bladder cancer	5.58e-06	5.13e-05	CbGpPWpGaD
Glucosamine—CYP2E1—Metabolism—ERCC2—urinary bladder cancer	5.48e-06	5.03e-05	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—EGFR—urinary bladder cancer	5.46e-06	5.02e-05	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—KRAS—urinary bladder cancer	5.16e-06	4.74e-05	CbGpPWpGaD
Glucosamine—CYP2E1—Metabolism—MTHFR—urinary bladder cancer	5.15e-06	4.73e-05	CbGpPWpGaD
Glucosamine—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	4.96e-06	4.56e-05	CbGpPWpGaD
Glucosamine—CYP2C19—Metabolism—GSTP1—urinary bladder cancer	4.89e-06	4.5e-05	CbGpPWpGaD
Glucosamine—CYP2C19—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	4.73e-06	4.35e-05	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—TP53—urinary bladder cancer	4.59e-06	4.22e-05	CbGpPWpGaD
Glucosamine—CYP2C19—Metabolism—TYMS—urinary bladder cancer	4.55e-06	4.18e-05	CbGpPWpGaD
Glucosamine—CYP2C19—Metabolism—GSTM1—urinary bladder cancer	4.5e-06	4.13e-05	CbGpPWpGaD
Glucosamine—CYP2C19—Metabolism—NCOR1—urinary bladder cancer	4.5e-06	4.13e-05	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—HRAS—urinary bladder cancer	4.39e-06	4.03e-05	CbGpPWpGaD
Glucosamine—CYP2C19—Metabolism—GPX1—urinary bladder cancer	4.31e-06	3.96e-05	CbGpPWpGaD
Glucosamine—CYP2C19—Metabolism—ERCC2—urinary bladder cancer	4.23e-06	3.88e-05	CbGpPWpGaD
Glucosamine—CYP2E1—Metabolism—PPARG—urinary bladder cancer	4.18e-06	3.84e-05	CbGpPWpGaD
Glucosamine—CYP2E1—Metabolism—CREBBP—urinary bladder cancer	4.01e-06	3.69e-05	CbGpPWpGaD
Glucosamine—CYP2C19—Metabolism—MTHFR—urinary bladder cancer	3.97e-06	3.65e-05	CbGpPWpGaD
Glucosamine—CYP2E1—Metabolism—PTGS2—urinary bladder cancer	3.29e-06	3.02e-05	CbGpPWpGaD
Glucosamine—CYP2C19—Metabolism—PPARG—urinary bladder cancer	3.22e-06	2.96e-05	CbGpPWpGaD
Glucosamine—CYP2C19—Metabolism—CREBBP—urinary bladder cancer	3.1e-06	2.84e-05	CbGpPWpGaD
Glucosamine—CYP2E1—Metabolism—PTEN—urinary bladder cancer	2.87e-06	2.63e-05	CbGpPWpGaD
Glucosamine—CYP2E1—Metabolism—EP300—urinary bladder cancer	2.73e-06	2.51e-05	CbGpPWpGaD
Glucosamine—CYP2C19—Metabolism—PTGS2—urinary bladder cancer	2.53e-06	2.33e-05	CbGpPWpGaD
Glucosamine—CYP2C19—Metabolism—PTEN—urinary bladder cancer	2.21e-06	2.03e-05	CbGpPWpGaD
Glucosamine—CYP2C19—Metabolism—EP300—urinary bladder cancer	2.11e-06	1.94e-05	CbGpPWpGaD
